Fatty Liver: all 1,462 studies
Page 13 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- A Hepatitis B With Hepatic Steatosis StudyStatus unknownNCT02392598
- Fatty Liver Disease Collaborative Research in ChinaStatus unknownNCT02391168
- Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASHCompletedNCT02390232
- Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in ChildrenCompletedNCT02383485Not applicable
- Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe ObesityActive, not recruitingNCT02378259Not applicable
- Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot StudyCompletedNCT02366052Phase 2
- Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02363309
- Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic SyndromeCompletedNCT02358928Not applicable
- Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority AdultsCompletedNCT02347007Not applicable
- Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese ChildrenWithdrawnNCT02337894Not applicable
- Involvement of Steatosis-induced Glucagon Resistance in HyperglucagonaemiaCompletedNCT02337660Not applicable
- The Effects of PXR Activation on Hepatic Fat ContentCompletedNCT02329405Phase 4
- Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and SteatosisStatus unknownNCT02307344Not applicable
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesCompletedNCT02303730Phase 4
- Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver DiseaseCompletedNCT02303314Phase 2/3
- Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DMCompletedNCT02289235Early Phase 1
- Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLDStatus unknownNCT02285218
- A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLDCompletedNCT02285205Phase 4
- The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver DiseaseCompletedNCT02283710Phase 2
- Metabolic Syndrome and Non-alcoholic Fatty Liver During PregnancyStatus unknownNCT02276144
- Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver ProgressionCompletedNCT02267148
- A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr DiseaseStatus unknownNCT02265276Phase 3
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRIWithdrawnNCT02263677Phase 4
- Effect of Exercise on Hepatic Fat in Overweight ChildrenCompletedNCT02258126Not applicable
- "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic PopulationStatus unknownNCT02248311
- Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes SubjectsCompletedNCT02242149Phase 3
- The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With FibrosisCompletedNCT02231333Not applicable
- Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight AdolescentsCompletedNCT02216552Phase 2/3
- Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT02213224Phase 4
- Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected PatientsCompletedNCT02210715Phase 4
- EXIT: Prospective Study of the Response to ExerciseCompletedNCT02204670
- Cardiac Steatosis in Cushing's SyndromeStatus unknownNCT02202902Not applicable
- Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric PatientsStatus unknownNCT02201160Phase 1/2
- The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease PatientsWithdrawnNCT02194894Not applicable
- The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver DiseaseStatus unknownNCT02178839Not applicable
- Plasma Betatrophin Levels in Non-alcoholic Fatty Liver DiseaseCompletedNCT02176811
- An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisStatus unknownNCT02174367
- Gut Microbiota and Modulation of Liver Damage in NAFLDCompletedNCT02158351
- Fatty Acids, Genes and Microbiota in Fatty LiverCompletedNCT02148471
- Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM SubjectsCompletedNCT02147925Phase 4
- Autonomic Dysfunction in Non-Alcoholic Fatty Liver DiseaseCompletedNCT02132780
- Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in DiabetesCompletedNCT02132442Phase 3
- Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLDStatus unknownNCT02124577
- Fatty Liver Disease in Obese ChildrenCompletedNCT02117700Phase 1/2
- Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in AdolescentsCompletedNCT02116192Not applicable
- MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismCompletedNCT02102646Phase 4
- DHA and Vitamin D in Children With Biopsy-proven NAFLDCompletedNCT02098317Phase 3
- Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy OutcomeCompletedNCT02083367
- Urinary Metabonomics of Two Major Patterns of NAFLDStatus unknownNCT02077283
- Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLDStatus unknownNCT02075164Not applicable
- Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT02068339Phase 3
- Genetic Polymorphisms, Steatosis and DiabetesCompletedNCT02045563
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT02038387Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic SteatohepatitisCompletedNCT02030977Phase 2/3
- Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except CirrhosisTerminatedNCT02029586Phase 2
- Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic HepatitisCompletedNCT02019056Phase 2
- High Fructose Corn SyrupCompletedNCT02018237Not applicable
- Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis PatientsCompletedNCT02009592Not applicable
- Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02006498Phase 2
- Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) PatientsCompletedNCT01999101Phase 2
- Association of Non-alcoholic Fatty Liver Disease and Diabetes MellitusCompletedNCT01997424Not applicable
- Omega 3 Supplementation in Fatty LiverCompletedNCT01992809Phase 3
- Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin TreatmentWithdrawnNCT01987310Not applicable
- Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.CompletedNCT01985009Not applicable
- Genetics of Fatty Liver Disease in ChildrenCompletedNCT01966627
- Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)CompletedNCT01958411
- The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty LiverStatus unknownNCT01956825Phase 4
- Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic SteatohepatitisStatus unknownNCT01950884Phase 4
- Purified Anthocyanin and Nonalcoholic Fatty Liver DiseaseCompletedNCT01940263Early Phase 1
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisCompletedNCT01934777Phase 3
- Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)CompletedNCT01919294Phase 2
- Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV CoinfectionCompletedNCT01900015Phase 4
- Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced FibrosisCompletedNCT01899859Phase 1
- Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01894438Not applicable
- The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver DiseaseCompletedNCT01876108Phase 2
- Non Invasive Assessment of Liver Fibrosis in Fatty Liver DiseaseCompletedNCT01874249Not applicable
- Intestinal Microbiota and NAFLD Pre and Post Bariatric SurgeryStatus unknownNCT01856465
- The Role of Non-Alcoholic Fatty Liver Disease in Gestational DiabetesTerminatedNCT01855386
- Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty LiverWithdrawnNCT01849081Not applicable
- The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT01834300Not applicable
- Impact of Bariatric Surgery on Nonalcoholic Fatty Liver DiseaseCompletedNCT01828528
- Effect of Mediterranean Diet on Non-alcoholic Fatty Liver DiseaseCompletedNCT01798719Not applicable
- The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic SteatohepatitisCompletedNCT01791959Phase 2/3
- Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical StudyStatus unknownNCT01791452
- Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver DiseaseCompletedNCT01766960Phase 1
- Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)CompletedNCT01761370Not applicable
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 PatientsCompletedNCT01761318Phase 4
- Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver DiseaseCompletedNCT01759628Phase 2
- China Action on Spine and Hip StatusCompletedNCT01758770
- Effects of Fat and Carbohydrates in Obese MenCompletedNCT01750021Not applicable
- THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOSStatus unknownNCT01735799
- Dietary Interventions in PrediabetesCompletedNCT01729078Not applicable
- Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese YouthCompletedNCT01725035
- Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT01720719Phase 4
- Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver DiseaseCompletedNCT01707914Not applicable
- Multimodal Approach in IBD PatientsStatus unknownNCT01705522
- Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese PatientsCompletedNCT01695083
- Telomere Parameters in Patients With Nonalcoholic Fatty LiverStatus unknownNCT01694342